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Stress alters the immune system and vaccination during this time may reduce vaccine 
response; whereas, growth implants may shift metabolism to enhance tissue deposition in 
exchange for energy required for immune response during bovine respiratory disease (BRD) 
challenge. This study was conducted to determine the effects of pentavalent respiratory 
vaccination timing with or without a hormonal growth implant on arrival (d 0) on health, 
performance, complete blood count, and vaccine response in high–risk, newly received stocker 
calves during a 42–d receiving period. Crossbred bull and steer calves (n = 385) were weighed 
(initial BW = 202 ± 4.1 kg), stratified by castrate status on arrival, and assigned randomly to 1 of 
4 treatments arranged in a 2 × 2 factorial: 1) arrival (d 0) vaccination, with implant (AVACIMP),    
2) arrival vaccination, without implant (AVAC), 3) delayed (d 14) vaccination, with implant 
(DVACIMP), 4) delayed vaccination, without implant (DVAC). The percentage of calves treated 
for BRD once, twice, or thrice was 80, 50 and 20%, respectively, but did not differ (P ≥ 0.12) 
among treatments. Likewise, days to initial BRD treatment was not affected by vaccine timing (P 
= 0.66) or implant (P = 0.24). Overall ADG (d 0 to 42) did not differ due to vaccination timing 
(P = 0.53) or implant (P = 0.64). White blood cell count was not different (P ≥ 0.76) among 
treatments, but exhibited a cubic response over time (P = 0.01), with counts increasing from d 0 
to d 28 prior to leveling off at the end of receiving (d 42). The neutrophil:lymphocyte ratio 
decreased (linear, P < 0.0001) throughout receiving. Bovine viral diarrhea virus type 1a antibody 
concentrations were greater (P = 0.02) for calves vaccinated on arrival and increased over time 
for both vaccine treatments (P = 0.01). Results indicate a hormonal growth implant administered 
on–arrival to high–risk stocker calves did not increase ADG. Morbidity rate was high but was 
not impacted by vaccine timing or implant. Vaccination on arrival increased bovine viral 
diarrhea virus type 1a antibody concentrations throughout receiving. 
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Morbidity and mortality from bovine respiratory disease (BRD) in newly weaned beef 
cattle continue to be the among the largest health problems facing the US beef cattle industry 
(Duff and Galyean, 2007). Prevention of BRD is important in order to limit the economic 
ramifications of BRD (Schneider et al., 2010). Cattle are classified as low, medium, or high risk 
for BRD based on the existence of predisposing factors to the disease. High-risk cattle are of 
unknown origin or background, have been commingled and purchased at local sale barns, and are 
transported various distances to purchasers. These cattle are more susceptible to BRD because 
they have not likely been vaccinated prior to commingling with exposed cattle during the 
marketing process, are exposed  to stress and environmental changes associated with marketing, 
and have a lower plane of nutrition for varying periods of time following marketing (Step et al., 
2008).  
Treatments using antibiotics as a preventative measure has decreased the incidence of 
BRD in high-risk beef cattle (Duff and Galyean, 2007); however, vaccination during processing 
on arrival may not allow adequate time to develop an immune response (Callan, 2001; Richeson 
et al., 2009). Stress may compromise the immune system, while previous exposure to disease 
may further reduce vaccine efficacy (Richeson et al., 2009) and animal performance. Delaying 
vaccination against BRD may allow high-risk cattle to overcome stress associated with weaning, 
and changes in feed and environment potentially allow a better response to vaccination. To date 
results from such approaches have been mixed. In two receiving studies by Richeson et al. (2008, 
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2009), delaying BRD vaccination 14-d improved health and performance in one study but had no 
effect on the second.  
Cattle are often implanted on arrival to improve performance during the receiving phase. 
Implants improve production gains, efficiencies, and yield of product in beef cattle finishing 
programs (Elam et al., 2009), and act to increase protein deposition (Baxa et al., 2010). 
Hormonal implants are used throughout each phase of beef cattle production (Mader, 1997); 
however, response to implants may be lower when several are used at various stages (Mader, 
1994).     
Further investigation of management strategies to reduce BRD incidence would limit 
associated cost, increasing economic returns for producers (Step et al., 2008). Use of implants in 
receiving cattle is among those production strategies heavily used in receiving cattle 
management. Serum concentrations of estradiol-17 beta peaked between d 0 and 14 of receiving 
in cattle implanted on arrival (Bryant et al., 2010), the period of highest stress in receiving cattle. 
Thus, the objective of this study was to determine the effects of BRD vaccination timing (d 0 or 
14) with or without  growth implant on arrival on health, performance, bovine viral diarrhea 
virus type 1a antibody concentrations, and immune measures of newly received beef calves.  
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Bovine Respiratory Disease 
Bovine respiratory disease (BRD) complex is among the largest health obstacles the 
cattle industry faces because of the high cost associated with management and treatment 
(Schneider et al., 2009). Cost of BRD results from morbidity, and mortality, but also from 
production losses measured by decreased average daily gain, expense of vaccine treatments, and 
additional labor costs of treating and managing sick cattle. New vaccines and antimicrobials have 
been introduced; however, BRD rates have not decreased overtime (Babcock et al., 2006), 
possibly because of the lack of use of preconditioning programs prior to marketing. 
Cow-calf producers in the Southeast United States historically fail to implement 
preconditioning programs including vaccination and management practices that can decrease the 
incidence of BRD in their cattle (NAHMS, 1997). In 2007, 61% of operations did not vaccinate 
beef calves for respiratory disease prior to leaving the farm for marketing. Calves that were not 
vaccinated made up 31% of the total calves sold in the United States (NAHMS, 2008a).Thus, 
management of BRD by stocker cattle producers is important on arrival to improve immune 
status prior to feedlot entry. According to Chirase and Greene (2001), BRD has been reported to 
cost the industry up to $750 million annually. With increasing feed and cost of hired labor, this 
estimated expense will continue to increase over time. 
Bovine respiratory disease involves the interaction of various infectious agents 
(infectious bovine rhinotracheitis, parainfluenza-3, bovine viral diarrhea virus, bovine respiratory 
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syncytial virus, Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni), as well 
as environmental conditions, and stress from handling, management, and US marketing 
procedures (Galyean et al., 1999, Taylor et al., 2010). These infectious agents work together and 
target cattle at the receiving stage when stress is greatest. Stress associated with weaning and 
receiving can affect calf health and performance by suppressing immune function,  increasing the 
risk from exposure to infectious agents , causing a combination of viral and bacterial infections 
(Arthington et al., 2008). Cattle that are commingled with unfamiliar cattle in an auction market 
setting are exposed to viral and bacterial agents and are at high risk for developing BRD.  
Predisposing Factors of BRD. Pre-weaning factors that contribute to BRD include poor 
nutritional status of the calf, lack of vaccination, and failure to wean calves prior to 
transportation and marketing. Stressed cattle will not consume feed and water comparable to 
healthy unstressed cattle ( Cole, 1996), and this reduction in nutrient intake and dehydration may 
also affect the immune system, resulting in increased morbidity and mortality (Duff and 
Galyean, 2007). Shipping and processing calves enhances predisposing factors by exposure to 
unsuitable environmental conditions and stress (Snowder et al., 2006). Calves are more 
susceptible to infectious agents when stress alters the respiratory mucosa of the calf, negatively 
affecting the immune system directly or through the effects of endogenous agents such as 
cortisol (Taylor et al., 2010).  
Classification of cattle into risk categories for BRD is common for receiving cattle 
management (Richeson et al., 2009). This strategy gauges the potential for cattle to contract 
BRD based on several factors prior to and post weaning. High-risk cattle are of unknown origin 
with no record of vaccination, seldom weaned prior to transportation to the sale barn, and are 
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commingled with calves of various origins during marketing. Level of stress, effect of stress on 
overall immunity, and exposure to infectious pathogens with no vaccination to prevent illness 
increase the incidence of BRD. During marketing cattle suffer from feed and water deprivation 
and are commingled with unfamiliar cattle exposing them to a greater amount of viral and 
bacterial pathogens, thus increasing the chances of contracting combinations of viral pathogens 
associated with BRD. Through the weaning and marketing process, calves may shrink as much 
as 10% or more depending on the overall disposition of cattle, distance to stocker facility, and 
adequacy of personnel to manage incoming cattle (Thrift and Thrift, 2011). Receiving 
management includes all strategies involved in processing and treating incoming sale barn 
stocker cattle with no previous records. Castration, dehorning, and vaccination are common 
procedures done at a time when cattle are already stressed from weaning and marketing.   
Viral and Bacterial Agents. Viral agents play a key role in initiating the BRD complex, acting as 
a primary challenge to the respiratory tract. Viruses are believed to predispose bacterial infection 
in 2 ways: 1) by directly damaging the clearance mechanisms of the respiratory system, and 2) 
by bacteria relocating from the upper respiratory tract into the already compromised portion of 
the lung (Taylor et al., 2010). Viral agents including infectious bovine rhinotraceitis (IBR), 
parainfluenza-3 (PI3), bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus 
(BRSV), and bovine enteric coronavirus have been associated with BRD in feedlot calves 
(Plummer et al., 2004). 
Infectious bovine rhinotracheitis is a herpes virus also known as bovine herpes virus 1, 
and commonly called red nose. An infection in the upper respiratory tract occurs in most groups 
of cattle with lowered immunity that have not been previously exposed to the disease. Symptoms 
of IBR include lesions on the muzzle, nasal discharge, runny eyes, coughing, lack of appetite, 
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and labored breathing, elevated temperature, ulcers in the upper respiratory tract, and destruction 
of the corpus luteum causing abortion. Viruses can spread by direct contact, breeding, in utero, 
during birth, and in airborne particles. Stressed animals shed the virus more rapidly increasing 
the issue of virus spread (Patel, 2005).    
The presence of BVDV may cause decreased fertility, abortions, congenital 
malformations, and intrauterine infections causing calves to be born persistently infected (PI) 
(Taylor et al. 2010). Calves that are infected with non-cytopathic BVDV from d 40 to d 125 of 
gestation will become immunotolerant and shed large quantities of BVDV for the remainder of 
their life and will not respond to vaccination (Duff and Galyean, 2007). According to a USDA 
survey, only 9% of operations had a calf that tested positive for PI BVDV and 0.12% of all 
calves tested were found to be positive via the ear notch test, but one calf can cause a great 
amount of morbidity within a herd. Testing for PI-BVDV, and removing infected calves will 
improve the health of other cattle in the same group (NAHMS, 2008b). The immune system 
responds to the persistent infection in order to control it but is not able to eradicate the disease, 
explaining the lack of symptoms of BRD in PI calves (Abbas et al., 2010).  
Bovine viral diarrhea virus is classified into 2 genotypes based on sequences from the 5’ 
untranslated region of the viral genome and are further characterized into subgenotypes 1 a, 2 b, 
2 a, and 2 b; furthermore, BVD is also classified into two biotypes which are cytopathic, a strain 
of BVDV that kills epithelial cells when cultured in vitro and non-cytopathic, a strain that does 
not kill epithelial cells when cultured in vitro (NAHMS, 2008b). 
The BVDV is unique in that it can cause an intrauterine infection resulting in PI calves. 
Millions of viral pathogens can thus be spread to cattle commingled with PI calves. Persistently 
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infected calves are a main source of disease in feedlots (O’Connor et al., 2005). The number of 
calves that are persistently infected is low, but one animal sheds millions of viral pathogens and 
can expose an entire pen to BVDV. The economic impact of PI calves may be high due to the 
potential for a greater exposure within the herd (Duff and Galyean, 2007). Most vaccines may 
not provide adequate protection against BVDV1b (Fulton et al., 2006). In a study by Longeragen 
et al. (2005), PI animals increased the risk of antimicrobial treatment for BRD by 43% compared 
to animals not exposed. Regardless of biotype or genotype, significant losses can occur in cattle 
infected with the viral agent with increased effects if all other predisposing factors are also 
present (Duff and Galyean, 2007). 
Wittum et al. (1996) screened 18,931 calves in 128 beef herds in 5 states for PI-BVDV. 
On the initial screening, 56 BVDV positive calves were found in 13 herds and 61% of the calves 
remained positive at 6 mo of age. According to Fulton et al. (2005), 1 PI calf caused 68.4% of 
morbidity in commingled calves. 
Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni are bacterial 
pathogens of primary concern with Mannheimia haemolytica serotype 1 being the organism most 
commonly associated with BRD (Pandher et al., 1998). Mycoplasma bovis is a bacterial agent 
that has recently become associated with those in the BRD complex. It is known to consistently 
cause chronic poor doers (Taylor et al., 2010). Pasteurella multocida is carried by many normal 
cattle and becomes a problem in combination with other agents. Cattle with H. somni show few 
clinical signs unless other systems are affected as with brain fever, also known as 
thromboembolic meningioencephalitis (TEME).  
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Signs and Clinical Symptoms of BRD. Health, the overall well-being of an animal, is determined 
by visual assessment of an animal by producers or personnel as well as further clinical 
measurements to confirm diagnosis of particular diseases. Initial assessment of health is often 
subjective and can be misjudged depending on the experience of the evaluator. Symptoms can be 
in any combination and may be harder to detect in cattle attempting to blend in with the herd. 
Because of a heavy reliance on visual signs for determining BRD, there is a high potential for 
incorrect diagnosis at this time (Galyean et al., 1999). 
Signs of BRD include evidence of depression such as hanging head, sunken or glazed 
eyes, slow movement, arched back, difficulty in rising, knuckling or dragging toes when 
walking, and stumbling. Abnormal appetite is often seen in addition to depression caused by 
respiratory distress. Animals can be completely off feed, eat less than or with less aggression 
than other animals, have lack of fill, or obvious BW loss. Morbid steers spend 30% less time at 
the feed bunk than healthy steers (Sewell et al., 1999). Respiratory signs of BRD include obvious 
labored breathing, extended head and neck, and noise when breathing.  
Diagnosis of BRD is less than optimal and a cost-effective method to more accurately 
detect infected animals or animals that are likely to develop BRD would be valuable (Duff and 
Galyean, 2007). Studies have shown that serum concentrations of haptoglobin on arrival were 
increased in steers that required more than one antimicrobial treatment (Carter et al., 2002; Berry 
et al., 2004). Serum haptoglobin measured on arrival may potentially be used as a predictor of 
clinical BRD. Serum haptoglobin concentrations were greater in auction market steers and steers 
weaned directly prior to shipping than preconditioned steers and arrival serum haptoglobin 
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concentrations were greater for steers requiring a greater number of treatments in a more recent 
study, agreeing with previous research (Step et al., 2008).  
Preconditioning 
Preconditioning is a method used by cow-calf producers to improve overall cattle health 
and gain performance by limiting stress, increasing feed intake at receiving, and reducing BRD 
at subsequent stages of beef cattle production. This management concept was developed to allow 
for a period of adjustment from weaning stress in order to improve the immune response of 
calves prior to the likely exposure to BRD pathogens during marketing and commingling (Thrift 
and Thrift, 2011).Most beef cattle are weaned immediately prior to marketing which can be one 
of the biggest stress factors for a calf (Boyles et al., 2007). Implementing a preconditioning 
program would allow for an adjustment period and alleviate this stress.   
Various programs have been developed and established with specific requirements for 
number of days weaned prior to sale, vaccination requirements, and calf identification. Cattle are 
preconditioned while still at their place of origin for 30- to 45- d post-weaning, depending on 
requirements of the program; however, periods of less than 30- d do not allow for enough gain 
for preconditioning to be cost effective for cow-calf producers (Thrift and Thrift, 2011). 
Typical preconditioning requirements include administration of parasiticids, vaccination 
against bacterial and viral pathogens with initial as well as booster vaccinations, dehorning, 
castration, and adjustment to feed bunks and water sources (Duff and Galyean, 2007). 
Vaccination programs used include 7- or 8- way clostridial vaccination, 4- or 5-way viral vaccine 
including IBR, PI-3, BVDV, and BRSV, Mannheimia haemolytica, Pasteurella multicocida, and 
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Histophilus somni are also included. Some vaccinations can be purchased in combination such as 
a 7-way clostridial vaccine including vaccination against bacterial agents. Administering a 
clostridial vaccination without also vaccinating calves for BRD pathogens will stimulate the 
immune system but will not prevent contracting BRD (Thrift and Thrift, 2011).  
Duff and Galyean (2007) found that preconditioning programs including pre-weaning 
viral vaccination programs, along with male castration, significantly decreased BRD in the 
feedlot. However, according to a USDA survey of cow-calf management practices (NAHMS, 
2008a), 56.1% of operations in the south central United States did not castrate bull calves before 
marketing.  Daniels et al. (2000) found that calves castrated upon arrival to the feedlot had a 
greater incidence of morbidity than calves that were castrated before arrival (35.8 vs, 18.6%). 
Mortality was also greater for calves castrated upon arrival compared to calves castrated before 
arrival.  
Step et al. (2008) conducted a trial that included three treatments of cattle received from a 
single source ranch that were 1) weaned 45 d prior to receiving, 2) weaned as well as vaccinated, 
or 3) weaned and immediately shipped, and compared these to auction market calves. Calves of 
ranch origin were less likely to be treated for BRD than those purchased through auction 
markets. Calves that were kept on the ranch 45 d after weaning were also less likely to develop 
BRD than market calves or calves directly received after weaning. Calves from a single source 
that are retained on the ranch for 45 d after weaning exhibit less morbidity and less health costs 
during the receiving period and at the feedlot than when cattle are commingled or trucked to the 
feedlot immediately after weaning (Step et al., 2008). Preconditioning improves health status of 
the animal and reduces the costly incidence of BRD throughout the feedlot phase.  
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Cost associated with BRD. Despite improved vaccines and antimicrobials, BRD rates have been 
increasing (Loneragen et al., 2005; Babcock et al., 2006; Holland et al., 2010) during recent 
years. In a recent study, Holland et al. (2010) used 360 British and British x Continental heifers 
assembled at the Western Kentucky Livestock Auction (Marion), and transported 957 km to 
Stillwater, OK to determine the effects of segregation and commingling. The newly received 
heifer calves were sorted into BRD-outcome groups to determine the effect on feedlot 
performance and carcass characteristics when heifers were fed to a similar carcass compositional 
endpoint. After the 63 d preconditioning phase, there was a linear decrease in BW as the number 
of treatments for BRD increased from 0 to 3. Body weight was 30 kg less for CI heifers than 
heifers treated 3 times for BRD. Similar decreases were seen during finishing and there was a 35 
kg difference between CI heifers and those treated 3 times and remained large at the end of the 
122 d finishing phase. Clinically ill heifers were 29 kg lighter than heifers treated 3 times, 
immediately before slaughter which contributes to the cost of BRD. Average daily gain declined 
linearly when including the preconditioning period as number of treatments for BRD increased. 
The overall ADG of CI heifers was less than those treated 3 times.  According to Fulton et al. 
(2002) feedlot cattle that received 1, 2, and 3 treatments for BRD returned $40.64, $58.35, and 
$291.93 less, respectively, than untreated animals. 
Loss of economic return is due to decreased carcass weight and reduced quality grade 
along with treatment costs (Gardner et al., 1999). In this study, a 4% decrease in ADG, 1.7% 
decrease in final BW, and a 2.6% decrease in HCW were reported for steers treated for BRD 
than for untreated steers. During a 1999 feedlot study, the average treatment cost was $12.59 
with 14.4% of cattle being treated (USDA, 2000). The cost of BRD reaches $92.26 when 
reduced ADG and lower carcass value are considered (McNeill et al., 1996).  
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Morbidity and Mortality of BRD. Bovine respiratory disease is the leading cause of morbidity 
and mortality according to a recent survey of US feedlots (Woolums et al., 2005). Bovine 
respiratory disease accounts for 70% to 80% of total morbidity and 40% to 50% of mortality 
(Smith et al., 1998).Timing of BRD treatment can be crucial in limiting results of the complex in 
the cattle industry.  
Holland et al. (2010) reported morbidity from BRD clinical signs were 57.6% falling 
within range of expected morbidity rates for calves with similar background in various other 
studies. Total mortality was 8.6% in this study. In recent experiments at the University of 
Arkansas using auction market cattle. Richeson et al. (2009) found similar morbidity from 
auction market cattle with 69% of cattle treated for BRD at least one time, and 1.9% death loss. 
In that study, morbidity ranged from 2.5% to 64%. Cattle were treated with clostridial and 
respiratory vaccination on arrival (ACAR), clostridial on arrival and respiratory vaccination 
delayed 14 d (ACDR), delayed clostridial 14 d with respiratory vaccination on arrival (DCAR), 
or delayed clostridial and delayed respiratory vaccination (DCDR). Morbidity and  mortality 
rates did not differ due to treatment.  
Timing of morbidity is also a factor in treatment. Thompson et al. (2006) found that 87% 
of first treatments occurred within the first 35 d. Disease timing, when measured relative to 
arrival and slaughter, affects performance and health outcomes. Management prior to entry into 
the stocker phase of production is also a variable when determining causes of increased 
morbidity and mortality. Different management strategies could be developed after insight into 




Longer transport distances for arriving calves were associated with an increased 
morbidity incidence. It is thought that increased stress is associated with the longer transit time 
but little data supports this at this time (Sanderson et al., 2008).  Concentrations of plasma 
glucose and lactate in cattle may be affected by the health status of incoming cattle.  Plasma 
glucose concentrations of heifers were linear with greatest concentrations for heifers never 
treated for BRD, and decreased for heifers treated. Plasma glucose was least when cattle were 
treated 3 times for BRD and considered morbid. This may have been due to disease challenge 
before processing (Montgomery et al., 2009).  
Current Preventative and Treatment Protocol for BRD.  Ensuring prevention of BRD is 
extremely important to avoid an epidemic outbreak and compounding economic cost associated 
with BRD (Schneider et al., 2010). Routine monitoring of the cow herd for potential viral or 
bacterial immunogens, or both, and administering annual boosters to the cows might result in 
transfer of greater levels of antibodies to the calves (Duff and Galyean, 2007). Also, Zimmerman 
et al. (2006) reported that a single dose of a modified live vaccine (MLV) containing BVDV 
administered at 4 to 5 wk of age stimulates a strong protective immune response against BVDV 
in calves. Vaccination is the most effective method for preventing and treating infections (Abbas 
et al., 2010).    
One common treatment protocol is if body temperature exceeds 104˚ F and clinical signs 
are exhibited for the disease, the animal should be treated using proper antibiotics. Antibiotics 
are the most effective method for treating infections (Abbas et al., 2010). After administering an 
antibiotic, the calf should be rechecked in 48 to 72 hr. If the calf is continuing to show clinical 
symptoms a second antibiotic can be administered. If the calf continues to show signs of BRD 
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and is not responding to antibiotics after a third treatment is administered, the calf is then 
considered chronic for the disease. 
According to Daniels et al. (2000), fewer calves were found to be morbid if administered 
a metaphylactic treatment of tilmicosin or florfenicol on arrival to the feedlot than control calves, 
however; it was not reported if risk was assessed. Hoar et al. (1998) used 220 feedlot calves 
diagnosed with BRD to compare the efficacy of tilmicosin administered once, and florfenicol 
administered twice at 48-h intervals to treat BRD and found that response to either therapy was 
similar. There is concern with cost of treatment and the potential overuse of antibiotics creating 
drug resistance (Hoar et al., 1998).  
The difference between vaccination and immunization can be confused. Vaccines are 
antigens along with adjuvant mixtures administered to induce protective immunity against 
microbial infections. Vaccines can be in the form of live avirulent or killed microorganisms to 
stimulate an immune response. Immunization is the successful establishment of an immune 
response to protect against infection caused by the vaccine administered. Immunity is the 
reaction of an animal’s immune system to a foreign substance, to protect against infectious 
disease. Immunity can be acquired by vaccination or from previous exposure to the virus or 
bacteria (Abbas et al., 2010).Vaccination does not ensure immunization will occur, and 
protection from disease is not guaranteed (Callan, 2001). It is desired for cattle to develop 
immunity to BRD and this immunity should occur after vaccination to limit losses in production. 
Given that BRD is a major problem for the beef industry, it seems logical that the 
industry should address BRD through genetics as well as management strategies (Thrift and 
Thrift, 2011). Genetic selection would be a slow process according to Snowder et al. (2006); 
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thus, if BRD is reduced in North America, it will be achieved most easily by specific changes in 
management techniques (Thrift and Thrift, 2011). 
Delaying Vaccination in Receiving Cattle. Stress, commonly associated with weaning, 
marketing, and shipment of feeder cattle, can compromise immune function, and vaccine 
administration during immunosuppression may reduce vaccine efficacy and performance 
(Richeson et al., 2008) throughout receiving and into the feedlot phase of production. Results for 
delayed vaccination studies vary resulting in different opinions and ideas for managing stressed 
cattle.  
Previous exposure to BRD pathogens may decrease efficacy of vaccination (Richeson et 
al., 2009) if administered on arrival at a stocker facility. In high-risk calves, the transportation 
stress period can endure for as long as 15 d post-arrival based on serum haptaglobin 
concentration of calves (Purdy et al., 2000). Much of the failure of vaccination may be timing of 
administration, failure of stressed calves to respond appropriately to vaccination, the 
multifactorial nature of BRD, and the increased susceptibility of stressed calves to all pathogens. 
This has introduced the idea of delaying processing until cattle have adjusted to the new 
environment and are alleviated of stress (Taylor et al., 2010). 
 In a study by Richeson et al. (2008) calves were assigned to one of two BRD vaccination 
treatments. Cattle were either vaccinated with a multivalent modified live virus (MLV) BRD 
vaccine on arrival (d 0) or delayed 14-d. Body weights were collected for performance data, 
morbidity was used to determine health, and blood samples were drawn for serum IBR antibody 
levels. Average daily gain was greater for  calves delayed vaccination from d 0 to d 14 (DMLV) 
and throughout the entire receiving study from d 0 to d 42. Morbidity rates for BRD were high 
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for all cattle but were unaffected by vaccination treatment along with days to first treatment, 
treatment cost, and mortality. Positive IBR antibody seroconversion was greater for DMLV 
calves on d 42 of the trial as well as d 28 and d 42  post vaccination, suggesting an improved 
immune response by delaying BRD vaccination 14-d.  
Richeson et al. (2009) found that BRD and clostridial vaccination timing did not affect 
ADG or morbidity of calves during the 56-d receiving period. Days to first treatment for BRD 
were less for cattle vaccinated with both clostridial and BRD vaccinations on arrival than cattle 
receiving delayed vaccinations. Cattle that received BRD vaccination on arrival developed 
greater BVDV type 1 antibody concentrations than delayed BRD vaccination.   
Use of Implants. The U.S. beef cattle industry currently uses growth-promoting implants as a 
common management practice to increase growth and reduce costs by improving feed efficiency 
of cattle (Roeber et al., 2000, Platter et al., 2003). Nutrition and management practices such as 
implanting that influence maintenance energy requirements could improve efficiency and 
decrease the cost of beef production in the U.S (Paisley et al., 1999). 
Implants work by slowly releasing growth stimulants over a period of time by increasing 
circulating levels of somatotropin and insulin-like growth-factor 1. This increase in circulating 
hormones increases the secretion of growth hormone, increasing muscle growth. Zeranol 
implants are synthetic estrogen implants, affecting female characteristics. The growth response 
will be greater for calves fed a higher plane of nutrition (Stewart, 2010).  
Steroidal hormones such as trenbolone acetate and estradiol and β-adrenergic agonists 
such as ractopamine hydrochloride and zilpaterol hydrochloride, improve production gains, feed 
efficiencies, and yield of product (Elam et al., 2009). Zeranol is an implant derived from mold 
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found on corn by Gibberella zeae. During 25 trials by the manufacturer, Ralgro increased the 
rate of gain of feedlot steers by 9.3 and 10.3% without any differences in carcass traits when fed 
the same number of days compared to untreated cattle. Implanted cattle were heavier at slaughter 
than cattle that were not implanted (Sewell, 1993). 
 Hormonal implants may be used prior to weaning, during the growing phase, and into 
finishing phases of cattle production (Mader, 1997; Platter et al., 2003). However, cumulative 
implant response may be lower when several implants are used at various stages of production 
(Mader et al., 1994). Mader et al. (1994) reported that cattle implanted post-weaning had 
increased dry matter intakes when placed directly in feedlots. 
Serum concentrations of estradiol-17β increase within 14-d after receiving the initial 
implant (Bryant et al., 2010) while stress is also high. This stress may reduce the efficacy of the 
implant administered at the beginning of the receiving period. If energy is partitioned for growth, 
this partitioning may alter immune function during a period when immune status is important 
after exposure to stress and various viral and bacterial agents during marketing and processing. 
Anabolic hormones may potentially modify metabolism to enhance growth and reduce energy 
that is required for immune function at this time. Implanting on arrival may decrease the efficacy 
due to stress and energy repartitioning, and increase morbidity by compromising the function of 
the immune system.  
A study was conducted to determine the effects of delaying BRD vaccination 14-d with 
or without a hormonal growth implant to determine the effects on health, performance, and 
immunity of newly received stocker calves. This study considered the problem with BRD that 
the US beef market faces, and the lack of preconditioning programs including vaccination of 
BRD prior to marketing and exposure to various pathogens. Current management strategies 
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include implanting on arrival to the stocker unit; however, little is known of the effect that 
implanting has on health and immune function of the calf during a high period of stress. 
Research was conducted to determine if delaying vaccination with or without implanting on 
arrival is efficacious to the overall health and BW gain performance of the calf. 
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Effects of respiratory vaccination timing and hormonal growth implant on health, 
performance, and immunity of high-risk, newly received stocker cattle 
ABSTRACT 
Stress alters the immune system and vaccination during this time may reduce vaccine 
response; whereas, growth implants may shift metabolism to enhance tissue deposition in 
exchange for energy required for immune response during bovine respiratory disease (BRD) 
challenge. This study was conducted to determine the effects of pentavalent respiratory 
vaccination timing with or without a hormonal growth implant on arrival (d 0) on health, 
performance, complete blood count, and vaccine response in high–risk, newly received stocker 
calves during a 42–d receiving period. Crossbred bull and steer calves (n = 385) were weighed 
(initial BW = 202 ± 4.1 kg), stratified by castrate status on arrival, and assigned randomly to 1 of 
4 treatments arranged in a 2 × 2 factorial: 1) arrival (d 0) vaccination, with implant (AVACIMP),    
2) arrival vaccination, without implant (AVAC), 3) delayed (d 14) vaccination, with implant 
(DVACIMP), 4) delayed vaccination, without implant (DVAC). The percentage of calves treated 
for BRD once, twice, or thrice was 80, 50 and 20%, respectively, but did not differ (P ≥ 0.12) 
among treatments. Likewise, days to initial BRD treatment were not affected by vaccine timing 
(P = 0.66) or implant (P = 0.24). Overall ADG (d 0 to 42) did not differ due to vaccination 
timing (P = 0.53) or implant (P = 0.64). White blood cell count was not different (P ≥ 0.76) 
among treatments, but exhibited a cubic response over time (P = 0.01), with counts increasing 
from d 0 to d 28 prior to leveling off at the end of receiving (d 42). The neutrophil:lymphocyte 
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ratio decreased (linear, P < 0.0001) throughout receiving. Bovine viral diarrhea virus type 1a 
antibody concentrations were greater (P = 0.02) for calves vaccinated on arrival and increased 
over time for both vaccine treatments (P = 0.01). Results indicate a hormonal growth implant 
administered on–arrival to high–risk stocker calves did not increase ADG. Morbidity rate was 
high but was not impacted by vaccine timing or implant. Vaccination on arrival increased bovine 
viral diarrhea virus type 1a antibody concentrations throughout receiving.  
Key Words: health, implant, management, receiving cattle, vaccine 
 
INTRODUCTION 
 Morbidity and mortality from bovine respiratory disease (BRD) in newly weaned 
beef cattle remains among the most frequent health problems facing the US beef industry (Duff 
and Galyean, 2007). Cattle are classified as low, medium, or high risk for BRD based on 
predisposing factors to the disease. High-risk cattle are of unknown origin or background, have 
been commingled, purchased at local sale barns, and transported various distances following 
purchase. These cattle are considered more susceptible to BRD because they have not likely been 
vaccinated and are commingled with exposed cattle during marketing (Smith, 2004). 
Treatments using antibiotics as a preventative measure have decreased the incidence of 
BRD in high-risk beef cattle (Duff and Galyean, 2007); however, other treatments such as 
vaccination during processing on arrival may not allow for time to develop an immune response 
(Callan, 2001). At this time stress may compromise the immune system, while exposure to BRD 
pathogens during marketing and transport may further reduce vaccine efficacy and calf 
performance (Richeson et al., 2009). While preweaning BRD vaccination is preferred, high-risk 
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newly-received calves that are allowed a period to recover from stress may respond more 
appropriately to modified-live virus BRD vaccination (Richeson et al., 2008). Delaying 
vaccination against BRD would allow high-risk cattle to overcome stress associated with 
weaning, and changes in feed and environment in order to better respond to vaccination. Results 
have been inconsistent in previous studies. In one study by Richeson et al. (2008), delaying BRD 
vaccination 14-d improved health and performance while in a second study (Richeson et al., 
2009) no improvements were observed.  
Stocker calves respond to implants by improving daily BW gains.  Cattle are implanted 
on arrival at stocker units to improve performance during the receiving phase. Implants improve 
production gains, feed efficiencies, yield of product in beef cattle finishing programs (Elam et 
al., 2009), and act to increase protein deposition (Baxa et al., 2010). Immune stimulation can 
result in decreased growth of an animal because nutrients are utilized for the immune system as 
priority over growth (Spurlock, 1997). Implanting may repartition the use of nutrients away from 
the immune system to growth and muscle deposition. 
Further investigation of management strategies to decrease the incidence of BRD would 
likely reduce associated cost, increasing economic returns (Step et al., 2008). Implanting is 
among the management strategies widely used in receiving cattle management. Serum 
concentrations of estradiol-17 beta peaked between d 0 and 14 of receiving in implanted cattle 
(Bryant et al., 2010), during the period of highest stress for receiving cattle.  Thus, the objective 
of this study was to determine the effects of BRD vaccination timing (d 0 or 14) with or without  
growth implant on arrival on health, performance, bovine viral diarrhea virus type 1antibody 
concentrations, and immune measures of newly received beef calves.  
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MATERIALS AND METHODS 
 
Animals and Management 
Animal methods were approved by the University of Arkansas Institutional Animal Care 
and Use Committee. A total of 385 high-risk crossbred bull and steer calves (initial BW = 202 ± 
4.1 kg) were purchased from a northern Arkansas auction barn and shipped to the University of 
Arkansas, Livestock and Forestry Research Station (LFRS), near Batesville, AR. Calves were 
received on 3 separate dates as each block in the experimental model: Sept. 13, 2010 (block 1, n 
= 175, 12 pens); Jan. 11, 2011 (block 2, n = 120, 8 pens); and Jan. 31, 2011 (block 3, n = 90, 5 
pens) and were divided into 12 total pens with 13 to 16 calves/pen. Each of the 4 treatments was 
replicated a total of 6 times (block 1, n = 3 pens/trt; block 2, n = 2 pens/trt; block 3, n = 1 
pen/trt).   
Treatment 
Upon arrival (d 0), calves were weighed, and individually identified, and assigned to 1 of 4 
vaccination and implant treatment strategies equally distributed by on-arrival castrate status, and 
BW on arrival (d 0). Treatments included: 1) arrival BRD vaccination (d 0) with implant 
(AVACIMP) 2) arrival vaccination (d 0) without implant (AVAC) 3) delayed vaccination (d 14) 
with implant (DVACIMP), and 4) delayed vaccination (d 14) without implant (DVAC).  
Vaccination treatment was administered on arrival or delayed 14-d with a 5-way modified-
live BRD vaccine injection (Bovi-Shield GOLD
®
5, Pfizer Animal Health, New York, NY). 
Booster vaccination was administered 14-d post initial vaccination. Calves were implanted on 
arrival with zeranol (Ralgro
®
, Intervet Schering-Plough Animal Health, Millsboro, DE), or not 
implanted based on assigned treatment group. 
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Calves were treated on arrival (d 0) for internal and external parasites with moxidectin pour 
on (Cydectin
®
, Fort Dodge Animal Health, Fort Dodge, IA), vaccinated using an 8-way 
clostridial (Covexin-8
 ®
, Intervet Schering-Plough Animal Health), and bulls were castrated by 
banding (California Bander
®
, InoSol, Co. LLC, El Centro, CA). Rectal temperature was 
measured (Model No. M216
®
, GLA Agricultural Electronics, San Luis Obispo, CA) at receiving, 
and calves were treated during initial processing when restrained in the chute using florfenicol 
and flumexine meglumine (Resflor®, Intervet Schering-Plough Animal Health) if considered 
morbid based on a rectal temperature ≥ 40°C. 
Cattle were observed each morning (0800) by experienced LFRS personnel for visual 
symptoms of respiratory illness. Personnel were not blinded to treatment, but cattle were not 
identified based on treatment during observation. Rectal temperature was taken for cattle 
exhibiting ≥ 2 visual symptoms of BRD and treatment was administered if rectal temperature 
exceeded 40° C. Treatment protocol included initial treatment with florfenicol and flumexine 
meglumine (Resflor
®
, Intervet Schering-Plough Animal Health). A second antibiotic treatment 
with tilmicosin (Micotil
®
, Elanco Animal Health, Indianapolis, IN) was administered if calves 
were still determined morbid by observation 72 h after initial treatment. Cattle requiring third 
antibiotic were administered enrofloxacin (Baytril
®
, Bayer Animal Health, Shawnee Mission, 
KS). Cattle were considered clinically morbid for BRD if not responsive to the third treatment 
and were given a final antibiotic treatment using tulathromycin (Draxxin
®
,Pfizer Animal Health). 
Blood Sampling and Analysis 
 Blood samples were collected via jugular venipuncture on d 0, 14, 28, and 42 using 10 
mL vacuum tubes containing EDTA (BD Inc., Franklin Lakes, NJ) to determine total and 
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differential white blood cell (WBC) concentrations, and untreated tubes to determine BVDV 
type 1a antibody virus neutralization (VN). Whole blood was chilled immediately and 
refrigerated within 5 h. Total WBC concentrations and differential WBC (lymphocytes, 
neutrophils, monocytes, eosinophils, and basophils) percentages, total red blood cells, 
hemoglobin, hematocrit, and platelets were determined within 24 h of collection using an 
automated hematology analyzer (Cell-Dyn 3500 system, Abbott Laboratoties, Abbot Park, IL) 
standardized for bovine blood analysis as described by Richeson et al. (2009).  
Blood for serum analysis was centrifuged at 2,100 x g for 20 min at 20° C and stored 
frozen at - 20°C until pooled for shipment and analysis. Serum was pooled by pen to determine 
BVDV type 1a antibody concentrations using the serum neutralization method described by 
Rosenbaum et al. (1970), and Richeson et al. (2009), by the Iowa State University College of 
Veterinary Medicine, Veterinary Diagnostic Laboratory, Ames, IA. The lowest dilution of serum 
was 1:2 and the greatest was 1:2048. Serum that did not provide protection at the 1:2 
concentration levels were reported as < 2 and considered negative for BVDV type 1a antibodies. 
Serum was considered positive if  a ≥ 2 value was reported.   
Statistical Analysis 
Treatment data were analyzed as a 2x2 factorial arrangement of treatments with pen 
identified as experimental unit. The class statement included block, vaccine treatment, implant 
treatment, gender, pen, and day. Block and block x pen x vaccine treatment x implant treatment 
were random effects. The model included vaccine treatment, implant treatment, day, and 
interactions. Gain performance data were analyzed using PROC MIXED procedure of SAS (SAS 
Institute Inc., Cary, NC). Date of arrival was the random block effect in the model. Blood 
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constituent data was analyzed as a repeated measures analysis. Day and treatment x day 
interactions were included in the model. Pen x block was the subject of the repeated statement 
for blood constituent analysis. Morbidity data were analyzed using PROC GLIMMIX of SAS. 
Significance was observed at (P < 0.05) and tendencies at (P < 0.10). For analysis of antibody 
concentration levels were transformed by log2 then analyzed for treatment and day effect and 
treatment x day interactions. 
RESULTS AND DISCUSSION 
Performance 
Performance data are presented in Table 1. There were no differences (P ≥ 0.53) observed for 
overall ADG throughout the duration of the 42-d receiving study and no differences (P ≥ 0.16) 
for ADG on any day interval throughout the receiving study. These results suggest no 
performance advantages of implanting or vaccinating receiving cattle on arrival vs delaying 
vaccination and not implanting during the first 42-d of receiving. There was no negative control 
in this study; however, DVAC received no treatment during the first 14-d of the receiving period 
and can be considered a negative control until vaccination as described by Richeson et al. (2008). 
Overall health of the receiving cattle was poor with 80% initial morbidity, potentially reducing 
implant efficacy. Upon receiving, cattle were likely recovering from a low plane of nutrition and 
stress potentially causing physiological changes within the animal. Lack of ADG increase is not 
typical for normal implanted cattle over non-implanted cattle; however, WBC parameters 
reported in this study suggest stress, dehydration, and inflammation prior to, during, and after 
administration of the implant may have reduced the efficacy of the implant by interfering with 
the growth hormone (GH) axis during the maximum time of hormone release from the implant. 
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Vaccination timing experiments differ in performance results, potentially due to health status 
of the calf and differing exposure to agents during the marketing process. Richeson et al. (2008) 
reported a greater ADG for calves that received a delayed (d 14) bovine respiratory disease 
vaccination (Express 5®, Boehringer Ingelheim Inc., St. Joseph, MO) while Richeson et al., 
(2009) reported no effect of vaccination timing on gain performance of the receiving cattle. 
Another difference among receiving studies includes antibiotics administered for metaphylaxis 
as well as prophylactic treatment for BRD, creating potential differences in results. In a study by 
Kreikemeier et al. (1996), cattle were either medicated for BRD or not medicated on either d 1 or 
21 of the receiving period including processing strategies with implanting, clostridial 
vaccinations, and BRD vaccination on either date. Cattle that were processed on d 1 of the study 
had increased ADG vs cattle that were processed on d 21 differing from our current study where 
implant had no effect on performance regardless of vaccine strategy. 
Clostridial vaccines such as those used in this study contain adjuvants used to enhance 
immune response to vaccines (Richeson et al., 2008). Effects of the use of clostridial vaccination 
in combination with BRD vaccination timing should be considered to determine effects on 
immune response to vaccine as well as efficacy reduction of the implant. Clostridial vaccines 
used in the current study may have shifted energy focus away from the implant to focus on 
immune response to overcome BRD morbidity seen on arrival; however, measures of energy 
metabolism were not done in this study. A study conducted by Chirase et al. (2001) found that 
cattle not receiving clostridial vaccination performed greater than calves vaccinated. Further 
research is needed to determine the effect of vaccination timing, implant, and other receiving 





 Morbidity (Table 2.) did not differ due to vaccine timing (P ≥ 0. 59) or implant treatment 
(P ≥ 0.35) but was extremely high, 80% of the total population received initial treatment for 
symptoms of BRD. Previous delayed vaccination studies showed morbidity rates of 67.5, and 
69% respectively (Richeson et al. 2008, 2009). Days to first treatment were < 2, but also did not 
differ due to study treatments (P ≥ 0.24). Cattle that were considered morbid and treated for 
symptoms of BRD were sick and treated on arrival or soon after arrival from the sale barn in the 
present study. Days to first treatment were low compared to previous research. Richeson et al. 
(2008, 2009) reported results whereby days to first treatment were ≥ 6 days after receiving. 
Retreatment of cattle was high with 50.4% of cattle in current study being treated twice 
compared to 26% of cattle requiring a retreat in the study by Richeson et al. (2008) and 35% 
reported by Richeson et al. (2009). Cattle requiring a third antibiotic treatment for BRD were 
25.4% in the current study which is slightly greater than but similar to Richeson et al. (2009)  
There was a numerical difference (P ≥ 0.20) for cattle treated 3 times for BRD, between 
AVACIMP and other treatments with 31.7% of AVACIMP cattle treated compared with 19.1% 
of AVAC, 25.3% of DVACIMP, and 25.5% of DVAC treated three times. Timing of vaccination 
with or without implant had no effect on morbidity rates of cattle at receiving. Variations in 
morbidity of receiving cattle may be a result of health and nutritional status on arrival and 
exposure to pathogens directly prior to arrival resulting in variations in performance.  
 
 
BVDV Type 1a Antibody Virus Neutralization 
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 There was a vaccination x day interaction (P = 0.01) for BVDV type 1a antibody VN 
(Figure. 1). Titers increased linearly throughout the receiving period for calves vaccinated on 
arrival. This response is similar to Richeson et al. (2009), reporting BVDV type 1a VN to be 
greater at d 14 for cattle vaccinated for BRD on arrival with or without a clostridial vaccination 
than cattle delayed respiratory vaccination 14-d. However, Richeson et al., (2009) also reported 
that all BVDV type 1 antibody VN were similar by the end of the receiving period (d 42); 
whereas in the current study, cattle vaccinated on arrival continued to have a greater antibody 
concentration than delayed vaccination with or without implant.  A tendency for a cubic effect (P 
= 0.08) of d post arrival occurred for calves receiving delayed BRD vaccination, titers decreased 
prior to vaccination followed by an increase similar to calves vaccinated on arrival throughout 
the receiving period. In Richeson et al. (2009), there was no treatment x day interaction for 
equivalent days post respiratory vaccination. As reported by Richeson et al. (2009), BVDV 
antibody concentrations support vaccination on arrival, which allowed a higher antibody 
response to vaccination than delayed vaccination regardless of stress on arrival at the beginning 
of the receiving period. Vaccine efficacy is dependent on antibody production which could 
potentially have a negative effect on health and performance (Burciaga-Robles et al., 2010) 
Similar to Richeson et al. (2009) morbidity due to vaccination timing did not decrease as 
reported in previous studies (Howard et al., 1989; Bolin and Ridpath, 1995), which were BVDV 
challenge studies and calves were limited to BVDV exposure unlike the current study and studies 






Total and Differential WBC Count 
No treatment effects were observed for vaccination or implant on total or differential 
WBC concentrations (P ≥ 0.76). Total WBC count was similar for all treatments (P ≥ 0.76), with 
a cubic day effect (P = 0.01), increasing prior to reaching a plateau at the end of the receiving 
period (d 42). Greater total WBC count may indicate a greater occurrence of pathogenic 
infection, or an increased immune response to an antigen from vaccination, allowing the animal 
to respond more quickly to a pathogenic infection which is the overall result and expectation of 
vaccination methods (Richeson et al., 2009). Percentage of lymphocytes increased linearly (P = 
0.001), and percentage of neutrophils decreased linearly (P ≤ 0.0001) through the end of 
receiving (d 42). Thus, the neutrophil:lymphocyte ratio (N:L), as an indicator of stress (McGlone 
et al., 1993; Gross and Siegel, 1983), decreased (linear, P ≤ 0.0001), throughout receiving. 
Similar results were found by Richeson et al. (2009), reporting decreasing N:L throughout 
receiving to be an indicator of stress during early receiving across all treatments. Richeson et al. 
(2009) also found that delaying clostridial and respiratory vaccinations 14-d may have reduced 
stress on arrival reporting a tendency for lower N:L for delayed vaccination over the receiving 
period.  
Percentage of eosinophils tended to increase linearly (P = 0.11) from d 0 to 14 and 
overall from d 0 to 42. Generally, circulating eosinophil numbers increase with the age of the 
animal until fully grown (Jain, 1993). Red blood cells were greatest on arrival and decreased 
(quadratic, P = 0.002) from d 0 throughout receiving. Increased red blood cells on arrival was 
likely due to dehydration from the period of marketing and transportation, and potentially 
contributing to stress and limiting implant efficacy. Platelets increased (quadratic, P = 0.02) and 
were greatest on d 14 prior to reaching equilibrium on d 42, similar to d 0 of the study, indicating 
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inflammation was greatest at d 14 of the study. Platelets tended (P ≥ 0.03) to be greater for 
AVAC on d 28 than 42, greater than AVACIMP on d 42, and greater than DVACIMP on d 42. 
Cattle vaccinated on arrival (AVAC) tended to have greater platelet counts on d 42 than 
AVACIMP on d 0, DVAC, and DVACIMP on d 14. Platelets decreased (linear, P < 0.0001) 
throughout receiving in cattle vaccinated on arrival with implant (AVACIMP). All total and 
differential WBC counts were within normal limits for bovine blood.  
In summary, there were no beneficial or detrimental effects of delaying BRD vaccination 
14-d on performance or morbidity rates of high-risk, newly received stocker calves. Implanting 
on arrival had no effect of performance and did not affect morbidity. Cattle vaccinated on arrival 
had increased BVDV type 1a antibody concentrations than cattle delayed vaccination 14-d. 
Increase in antibody concentration continued throughout the end of the 42-d receiving period.  
    




AVACIMP = arrival (d 0) bovine respiratory disease vaccination with implant 
2
AVAC = arrival bovine respiratory disease vaccination without implant 
3
DVACIMP = delayed (d 14) bovine respiratory disease vaccination with implant 
4
DVAC = delayed bovine respiratory disease vaccination without implant 
5
VACC = main effect of bovine respiratory disease vaccination timing (d 0 vs 14) 
6
 IMP = main effect of implant vs not implanting; Interaction = vaccine timing x implant strategy 
  
Table 1. Effect of bovine respiratory disease vaccination timing and hormonal growth implant on performance of 
newly received stocker cattle 































Initial BW, kg 203 203 202 200 4.41 0.34 0.75 0.77 
Final BW, kg 240 239 241 237 11.3 0.91 0.50 0.65 
ADG, kg         
d 0 to 14 0.79 0.93 0.71 0.67 0.31 0.28 0.73 0.54 
d 14 to 28 0.96 0.84 1.1 1.04 0.18 0.16 0.45 0.80 
d 28 to 42 0.94 0.89 0.91 0.94 0.19 0.81 0.79 0.55 






AVACIMP = arrival (d 0) bovine respiratory disease vaccination with implant 
2
AVAC = arrival bovine respiratory disease vaccination without implant 
3
DVACIMP = delayed (d 14) bovine respiratory disease vaccination with implant 
4
DVAC = delayed bovine respiratory disease vaccination without implant 
5
VACC = main effect of bovine respiratory disease vaccination timing (d 0 vs 14) 
6
IMP = main effect of implant vs not implanting; Interaction = vaccine timing x implant strategy 
 
 
Table 2. Effect of bovine respiratory disease vaccination timing and hormonal growth implant on health of 
newly received stocker cattle 































Morbidity, %         
Pull 1 74.1 82.9 84.9 79.6 12.3 0.62 0.44 0.82 
Pull 2 50.1 48.0 55.0 48.4 14.4 0.68 0.50 0.73 
Pull 3 31.7 19.1 25.3 25.5 8.7 0.91 0.51 0.20 
Pull 4 7.6 14.7 13.1 12.2 9.6 0.59 0.35 0.25 
Day to 1
st







Figure 1. Effect of bovine respiratory disease vaccination timing and hormonal growth implant 
on BVDV Type 1a antibody concentrations of newly received stocker cattle 
  
    Figure 1. Effect of bovine respiratory disease vaccination timing and implant on bovine viral 
diarrhea virus (BVDV) type 1a antibody concentrations of newly received stocker cattle. VAC x 
day interaction (Cubic, P = 0.08). Effect of vaccine treatment x day (P = 0.01). No effect of IMP 
treatment (P = 0.52). AVACIMP = arrival (d 0) bovine respiratory disease (BRD) vaccination 
with implant; AVAC = arrival BRD vaccination without implant; DVACIMP = delayed BRD 












































Day Lin = Linear effect of day  
2
Day Quad = Quadratic effect of day 
3
Day Cubic = Cubic effect of day 
4
N:L ratio = neutrophil:lymphocyte ratio 
 
 
Table 3. Effect of bovine respiratory disease vaccination timing and hormonal growth implant on complete and 
differential white blood cell concentrations of newly received cattle  
  P-value 








White blood cells, n x 10 
3
/ µL 8.22 8.09 9.35 8.56 0.41 0.06 0.26 0.01 
Neutrophils, % 39.8 34.6 34.0 31.8 1.8 <0.01 0.11 0.18 
Lymphocytes, % 44.7 48.5 48.5 51.22 2.1 <0.01 0.65 0.23 
Monocytes, % 13.6 14.8 15.3 14.7 0.92 0.06 0.06 0.84 
Eosinophils, % 0.61 0.92 0.86 1.01 0.12 0.01 0.40 0.24 
N:L ratio
4
 1.2 1.09 0.95 0.90 0.11 <0.0001 0.64 0.67 
Monocytes, % 13.6 14.8 15.3 14.7 0.92 0.06 0.06 0.84 
Red Blood Cells, n x 10
6
/µL 10.5 9.35 9.46 9.69 0.22 <0.0001 <0.0001 0.002 
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CHAPTER IV  
CONCLUSION 
Results from various receiving studies are contradicting at this time. Cattle were stressed 
on arrival and stress was alleviated throughout receiving. In the current study there were no 
beneficial or detrimental effects of delaying BRD vaccination 14-d on performance or morbidity 
rates of high-risk, newly received stocker calves. Implanting on arrival had no effect of 
performance and did not affect morbidity. Cattle vaccinated on arrival had increased BVDV type 
1a antibody concentrations than cattle delayed vaccination 14-d. Increase in antibody 
concentration continued throughout the end of the 42-d receiving period.   
 
 
